Nebulization as the mode to administer therapeutic bacteriophages to resolve Acinetobacter pneumonia in rabbits

---

Original Article

Author Details : VinodKumar C.S*, Ananya V Swamy, Shreshta Shamanur, Arpitha Venkatareddy, V.L Jayasimha, Sriman Narayan Reddy, Susan Jyothica Dsouza, Srinivasa H

Volume : 7, Issue : 3, Year : 2022

Article Page : 130-137

https://doi.org/10.18231/j.ijirm.2022.029

Suggest article by email

Get Permission

---

Abstract

Introduction: Multidrug-resistant strains of Acinetobacter baumannii, a significant hospital pathogen, have developed resistance to virtually all available antibiotics. Carbapenems antibiotics are among the most commonly used antibiotics against Acinetobacter infections, but they can be rendered ineffective by the metallo-beta-lactamase enzyme. In this study, bacteriophage isolated against blaSPM-1 producing Acinetobacter baumannii was evaluated for its therapeutic potential in the rabbit pneumonia model.
Materials and Methods: Acinetobacter baumannii was isolated from the sputum and was speciated as per the standard microbiological techniques. Bacteriophage specific for blaSPM-1 producing Acinetobacter baumannii from the sewage water. Pneumonia was introduced in the rabbits as per Esposito Pennington method and efficacy of the bacteriophage in resolving pneumonia was evaluated. For in-vivo experiments, five groups of rabbits were used including infection-free, phage control, bacteria-infected control, and the other two groups infected with Acinetobacter baumannii and treated either with an antibiotic, colistin (2.5 mg/kg, twice a day intraperitoneally) or Acinetobacter phage (3×10⁹ PFU/mL, given once through
nebulizer). The experimental animals were monitored for 72 hours for mortality, and the surviving rabbits were killed for bacteriological and histopathological analysis.
Results: In the infected group, pneumonia was developed within 48 hours, and 6/10 animals were dead after 72 hours. All the animals in the antibiotic group survived but showed signs of pneumonia, and there was up to 4 log CFU/g±0.24 reduction in the bacterial count. In phage treated group, all the animals survived at the end of 72 hours and all the animals were healthy with no signs of pneumonia.
Conclusions: The experiment showed new insights into the application of bacteriophage through nebulization, a non-invasive method of phage delivery to rescue rabbits from pneumonia caused by blaSPM-1-producing Acinetobacter baumannii.

Keywords: Rabbit models, bla SPM­1, Acinetobacter baumannii, Nebulization, Phage therapy, Pneumonia.

How to cite : C.s V , Swamy A V, Shamanur S, Venkatareddy A, Jayasimha V, Reddy S N, Dsouza S J, Srinivasa H, Nebulization as the mode to administer therapeutic bacteriophages to resolve Acinetobacter pneumonia in rabbits. IP Indian J Immunol Respir Med 2022;7(3):130-137

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.